Altshuler Shaham’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Altshuler Shaham’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-89,200	Closed	-$1.58M	–	329
2018 Q3	$1.58M	Hold	89,200	–	–	0.08%	73
2018 Q2	$1.23M	Buy	+89,200	New	+$1.06M	0.1%	76

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Altshuler Shaham's ECYT Position: Q4 2018 in Review

Altshuler Shaham sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 89,200 shares — an estimated $1.58M sold.

Altshuler Shaham first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $1.58M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Altshuler Shaham reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Altshuler Shaham sold 89,200 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.58M.
Altshuler Shaham first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Altshuler Shaham's Endocyte, Inc. Common Stock position peaked at $1.58M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Altshuler Shaham's 13F filing for Q4 2018, filed 11 Feb 2019.